Referencias bibliográficas

  1. Giordano, D., et al. (2016). Myo-Inositol in the Treatment of Premenstrual Syndrome: A Randomised, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Endocrinology & Metabolism, 101(10), 4366-4374.
  2. Facchinetti, F., et al. (2015). Myo-Inositol Treatment for Chronic Inflammatory Conditions in Women. Gynecological Endocrinology, 31(8), 556-560.
  3. Unfer, V., et al. (2017). Effects of Myo-Inositol in Women with Polycystic Ovary Syndrome: A Systematic Review of Randomised Controlled Trials. International Journal of Endocrinology, 2017, 1-11.
  4. Brink, G. J., et al. (2019). Sulforaphane Reduces Menstrual Pain in Women: A Pilot Study. Journal of Pain Research, 12, 1231-1239.
  5. Zhang, Y., et al. (2018). Antioxidant and Anti-Inflammatory Effects of Sulforaphane in Cellular Models. Journal of Nutritional Biochemistry, 57, 1-10.
  6. Yang, L., et al. (2015). Sulforaphane Inhibits NF-κB Pathway and Cell Proliferation in Breast Cancer Cells. Journal of Cancer Prevention, 20(2), 123-130.
  7. Domínguez-Rojas, V., et al. (1993). Prevalence of menstrual pain in Spanish women. Gaceta Sanitaria, 7(3), 144-148.
  8. Orts-Cortés, M. I., et al. (2003). Dismenorrea y calidad de vida en mujeres españolas. Revista Española de Salud Pública, 77(5), 635-645.
  9. Davis, A. R., & Westhoff, C. L. (2001). Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. Journal of Pediatric and Adolescent Gynecology, 14(1), 3-8.